IFF Expands Latin American Enzyme Production with Argentina Hub and Brazil Lab
Event summary
- IFF is transforming its Arroyito site in Argentina into its first full fermentation-based enzyme production hub in Latin America.
- The company is also opening a household care application laboratory at its Innovation Center in Brazil.
- These enhancements aim to improve speed, reliability, and locally relevant solutions for markets including brewing, animal nutrition, biofuels, and home care.
- The investments are part of IFF's strategy to support the growth of its Health & Biosciences business in Latin America.
- The Arroyito site will now produce enzymes locally from the initial biological stage, improving performance reliability and processing efficiency.
The big picture
IFF's investments in Latin America reflect a strategic focus on regional market growth, leveraging fermentation technology to enhance production efficiency and customer collaboration. The move aligns with broader industry trends toward localized manufacturing and bioscience-enabled solutions in emerging markets. With Latin America being one of IFF's fastest-growing regions, these enhancements position the company to capture future growth across multiple sectors.
What we're watching
- Regional Market Penetration
- How IFF's localized production capabilities will affect its competitiveness in Latin America's growing bioscience markets.
- Customer Collaboration
- Whether the new application lab in Brazil will accelerate product development cycles for household care customers.
- Operational Efficiency
- The pace at which IFF can scale its fermentation-based enzyme production to meet evolving customer needs.
Related topics